Top Stories
Brainomix's 360 E-lung software found that patients treated with taladegib had "significant positive differences" in lung volume, overall interstitial lung disease burden and total fibrosis extent.
In separate studies, CART produced usable readings for about 80% of a 24-hour period in atrial fibrillation patients and closely matched a standard 24-hour blood pressure monitor in severe heart failure.
Rentosertib, now in Phase III trials for idiopathic pulmonary fibrosis, showed age-reversal signals that appeared partly independent of improvements in lung function, pointing to potential anti-aging effects beyond its respiratory benefits.
The study showed Nautilus' technology could detect subtle differences in tau that are difficult to capture with conventional protein analysis.
The smart-ring maker generated $1.21 billion in revenue and $60.8 million in net income in the most recent nine-month financial period, while subscription revenue more than doubled.
Conference News
VR represents a low-cost, scalable intervention that improves patient experience while supporting efficient use of imaging resourcesContact: Katie Glenn, kglenn@acc.org ORLANDO (Sep 08, 2026) - Patien...
In a third of cases, AI chatbots wrongly reassure sleep apnoea patients that their symptoms are not serious, discouraging them from seeking a referral to a specialist, according to research presented ...
Glendale, CA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- LigoLab, a provider of integrated laboratory software solutions, is marking a successful appearance at ADLM 2026, where hundreds of participants visite...
Three studies explore the relationship between tumor microenvironment, genomic alterations, and treatment response in non-small cell lung cancer using AI-based analysisSEOUL, South Korea, Sept. 8, 202...
- First to demonstrate clinical utility of ring-type BP monitoring in AF and heart failure patients- Highlighted CART blood pressure monitor's multifaceted value, including ESH-based validation and sl...
